This trial is !
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Peripartum Cardiomyopathy
and you are a woman who is
Phase
4
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

Peripartum cardiomyopathy (PPCM) is a global disease with significant morbidity and mortality, and Nigeria probably has the highest burden of the disease in the world. Unfortunately, much about the disease including its aetiology, epidemiology and treatment is not yet well described. This will be a prospective, national, multicenter cohort study, conducted in centres in Nigeria. It is expected that approximately 500 patients with PPCM and 500 apparently healthy pregnant women will be recruited over a 6-month period with follow‐up at 3-monthly intervals for 18 months.

Provided treatments

  • Drug: Oral Sodium Selenite 200 µg/day for 3 months
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03081949. The sponsor of the trial is Aminu Kano Teaching Hospital and it is looking for 500 volunteers for the current phase.
Official trial title:
Peripartum Cardiomyopathy in Nigeria (PEACE) A Registry to Study the Demographics, Social and Clinical Characteristics, Pathophysiology and Outcomes of Peripartum Cardiomyopathy in Nigeria